Pharmacokinetics of kanamycin in the developing rat

Hearing Research

Volumn 99, Issue 1-2, 1996, Pages 85-90

  Henley, Charles M ^a   Weatherly, Robert A ^b   Ou, Ching Nan ^a   Brown, R Don ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

developing rat; kanamycin; ototoxicity; pharmacokinetics

Indexed keywords

KANAMYCIN;

AGE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NEWBORN; NONHUMAN; OTOTOXICITY; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANTI-BACTERIAL AGENTS; COCHLEA; HALF-LIFE; INJECTIONS, INTRAMUSCULAR; KANAMYCIN; MALE; RATS;

EID: 0030587174     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5955(96)00094-9     Document Type: Article

References (46)

1. Astbury, P.J. and Read, N.G. (1982) Kanamycin induced ototoxicity in the laboratory rat. Arch. Toxicol. 50, 267-278.
2. Axline, S.G., Yaffe, S.J. and Simon, H.J. (1967) Clinical pharmacology of antimicrobials in premature infants. II. Ampicillin, methacillin, oxacillin, neomycin and colistin. Pediatrics 39, 97-107.
3. Bernard, P.A. (1981) Freedom from ototoxicity in aminoglycoside treated neonates: a mistaken notion. Laryngoscope 91, 1985-1994.
4. Bernard, B., Garcia-Cázares, S.J, Ballard, Ch.A., Thrupp, L.D., Mathies, A.W. and Wehrle, P.F. (1977) Tobramycin: maternal-fetal pharmacology. Antimicrob. Agents Chemother. 11, 688-694.
5. Bernard, P.A., Pechere, J.C. and Hebert, R. (1980) Altered objective audiometry in aminoglycosides-treated human neonates. Arch. Otorhinolaryngol. 228, 205-210.
6. Bräunlich, H. (1981) Excretion of drugs during postnatal development. Pharmac. Ther. 12, 299-320.
7. Brown, A.M. (1987) Acoustic distortion from rodent ears: a comparison of responses from rats, guinea pigs and gerbils. Hear. Res. 31, 25-37.
8. Brown, R.D. and Manno, J.E. (1978) ESTRIP, a BASIC computer program for obtaining initial polyexponential parameter estimates. J. Pharm. Sci. 67, 1687-1691.
9. Brown, M.P., Stover, S.M., Kelly, R.H. and Farver, T.B. (1981) Kanamycin sulfate in the horse: serum, synovial fluid, peritoneal fluid, and urine concentrations after single-dose intramuscular administration. Am. J. Vet. Res. 42, 1823-1825.
10. Brown, A.M., McDowell, B. and Forge, A. (1989) Acoustic distortion products can be used to monitor the effects of chronic gentamicin treatment. Hear. Res. 42, 143-156.
11. Carlier, E. and Pujol, R. (1980) Supra-normal sensitivity to ototoxic antibiotic of the developing rat cochlea. Arch. Otorhinolaryngol. 226, 129-133.
12. Clarke, C.R., Short, C.R., Hsu, R.C. and Baggot, J.D. (1985) Pharmacokinetics of gentamicin in the calf: developmental changes. Am. J. Vet. Res. 46, 2461-2466.
13. Crowley, D.E. and Hepp-Reymond, M.-C. (1966) Development of cochlear function in the ear of the infant rat. J. Comp. Psychol. 62, 427-432.
14. Cummings, L.E., Guthrie, A.J., Harkins, J.D. and Short, C.R. (1992) Pharmacokinetics of gentamicin in newborn to 30-day-old foals. Am. J. Vet. Res. 51, 1988-1992.
15. Fox, K.E. and Russell, N.J. (1987) Pharmacokinetics of kanamycin in the bullfrog, Rana Catesbeiana. Comp. Biochem. Physiol. 87C, 245-250.
16. Green, S.L. and Conion, P.D. (1993) Clinical pharmacokinetics of amikacin in hypoxic premature foals. Equine Vet. J. 25, 276-280.
17. Hawkins, J.E. (1976) Drug ototoxicity. In: Wolf D. Keidel and W.D. Neff (Eds.), Handbook of Sensory Physiology, Vol. 5, Springer, Berlin, pp. 707-748.
18. Henley, C.M. (1994) Kanamycin depletes cochlear polyamines in the developing rat. Otolaryngol. Head Neck Surg. 110, 103-109.
19. Henley, C.M. and Hung, R. (1995) Sensitive period for kanamycin ototoxicity coincides with the period of kanamycin-induced depletion of cochlear polyamines in the developing rat. Assoc. Res. Otolaryngol. 18, 110.
20. Henley, C.M. and Rybak, L.P. (1995) Ototoxicity in developing mammals. Brain Res. Rev. 20, 68-90.
21. Henley, C.M. and Schacht, J. (1988) Pharmacokinetics of aminoglycoside antibiotics in blood, inner-ear fluids and their relationship to ototoxicity. Audiology. 27, 137-146.
22. Henley, C.M., Owings, M.H., Stagner, B.B., Martin, G.K. and Lonsbury-Martin, B.L. (1990) Postnatal development of 2f1-f2 otoacoustic emissions in pigmented rat. Hear. Res. 43, 141-148.
23. Henley, C.M., Weatherly, R.A., Martin, G.K. and Lonsbury-Martin, B.L. (1996) Sensitive developmental periods for kanamycin ototoxic effects on distortion-product otoacoustic emissions. Hear. Res. 98, 93-103.
24. Henry, K.R., Chole, R.A., McGinn, M.D. and Frush, D.P. (1981) Increased ototoxicity in both young and old mice. Arch. Otolaryngol. 107, 92-95.
25. Hosokawa, H., Nyu, S., Nakamura, K., Mifune, K. and Nakano, S. (1993) Circadian variation in amikacin clearance and its effects on efficacy and toxicity in mice with and without immunosupression. Chronobiol. Int. 10, 259-270.
26. Izquierdo, M., Lanao, J.M., Cervero, L., Jimenez, N.V. and Dominguez-Gil, A. (1992) Population pharmacokinetics of gentamicin in premature infants. Ther. Drug Monit. 14, 177-183.
27. Kenyon, C.F., Knoppert, D.C., Lee, S.K., Vandenberghe, H.M. and Chance, G.W. (1990) Amikacin pharmacokinetics and suggested dosage modifications for the preterm infant. Antimicrob. Agents Chemother. 34, 265-268.
28. Lenoir, M., Marot, M. and Uziel, A. (1983) Comparative ototoxicity of four aminoglycoside antibiotics during the critical period of cochlear development in the rat. Acta Otolaryngol. Suppl. 405, 1-16.
29. Lenoir, M. and Puel, J. (1987) Development of 2f1-f2 otoacoustic emissions in the rat. Hear. Res. 29, 265-271.
30. Lin, L., Grenier, L. and Bergeron, Y. (1994) Temporal changes of pharmacokinetics, nephrotoxicity, and subcellular distribution of tobramycin in rats. Antimicrob. Agents Chemother. 38, 54-60.
31. Ling, G.V., Conzelman, G.M., Franti, C.E. and Ruby, A.L. (1981) Urine concentrations of gentamicin, tobramycin, amikacin, and kanamycin after subcutaneous administration to healthy adult dogs. Am. J. Vet. Res. 42, 1792-1794.
32. Lonsbury-Martin, B.L, Martin, G.K., Probst, R. and Coats, A.C. (1987) Acoustic distortion products in rabbit ear canal. I. Basic features and physiological vulnerability. Hear. Res. 28, 173-189.
33. Lyos, A.T., Winter, W.E and Henley, C.M. (1992) Kanamycin inhibits cochlear-renal ODC in neonatal rats. Otolaryngol. Head Neck Surg. 107, 501-510.
34. Marot, M., Uziel, A. and Romand, R. (1980) Ototoxicity of kanamycin in developing rats: relationship with the onset of the auditory function. Hear. Res. 2, 111-113.
35. Marean, G.C., Cunningham, D., Burt, J.M., Beecher, M.D. and Rubel, E.W. (1995) Regenerated hair cells in the European starling: are they more resistant to kanamycin ototoxicity than original hair cells? Hear. Res. 82, 267-276.
36. Marre, R., Tarara, N., Louton, T. and Sack, K. (1980) Age-dependent nephrotoxicity and the pharmacokinetics of gentamicin in rats. Eur. J. Pediatr. 133, 25-29.
37. Martin, G.K., Lonsbury-Martin, B.L., Probst, R., Scheinin, S.A. and Coals, A.C. (1987) Acoustic distortion products in rabbit ear canal. II. Sites of origin revealed by suppression contours and pure-tone exposures. Hear. Res. 28, 191-208.
38. Onejeme, A.U. and Khan, K.M. (1984) Morphologic study of effects of kanamycin on the developing cochlea of the rat. Teratology 29, 57-71.
39. Osako, S., Tokimoto, T. and Matsuura, S. (1979) Effects of kanamycin on the auditory evoked responses during postnatal development of the hearing of the rat. Acta Otolaryngol. 88, 359-368.
40. Prieve, B.A. and Yanz, J.L. (1984) Age-dependent changes in susceptibility to ototoxic hearing loss. Acta Otolaryngol. 98, 428-438.
41. Pujol, R. (1986) Periods of sensitivity to antibiotic treatment. Acta Otolaryngol. (Suppl.) (Stockh.) 429, 29-33.
42. Pujol, R. and Hilding, D. (1973) Anatomy and physiology of the onset of auditory function. Acta Otolaryngol. 76, 1-10.
43. SAS Institute, Inc. SAS/STAT User's Guide (6.03 edition). SAS Institute, Inc., Cary, NC, 1988, pp. 1028.
44. Song, J., Ohdo, S., Ogawa, N. and Nakano, S. (1993) Influence of feeding schedule on chronopharmacological aspects of gentamicin in mice. Chronobiol. Int. 10, 338-348.
45. Stahlmann, R., Chahoud, I., Meister, R., Düerkop, C. and Neubert, D. (1988) Gentamicin plasma concentrations in pregnant and non-pregnant rats and fetuses after single and multiple injections. Arch. Toxicol., 62, 232-235.
46. Yoshiyama, Y., Nishikawa, S., Sugiyama, T. et al., (1993) Influence of circadian-stage-dependent dosing schedule on nephrotoxicity and pharmacokinetics of isepamicin in rats. Antimicrob. Agents Chemother. 37, 2042-2043.